106 related articles for article (PubMed ID: 9029058)
1. Major metabolic pathway for N-methyl-2-pyrrolidone in humans.
Akesson B; Jönsson BA
Drug Metab Dispos; 1997 Feb; 25(2):267-9. PubMed ID: 9029058
[TBL] [Abstract][Full Text] [Related]
2. Human experimental exposure to N-methyl-2-pyrrolidone (NMP): toxicokinetics of NMP, 5-hydroxy- N-methyl-2-pyrrolidone, N-methylsuccinimide and 2-hydroxy- N-methylsuccinimide (2-HMSI), and biological monitoring using 2-HMSI as a biomarker.
Jönsson BA; Akesson B
Int Arch Occup Environ Health; 2003 May; 76(4):267-74. PubMed ID: 12684812
[TBL] [Abstract][Full Text] [Related]
3. Concentrations of N-methyl-2-pyrrolidone (NMP) and its metabolites in plasma and urine following oral administration of NMP to rats.
Carnerup MA; Saillenfait AM; Jönsson BA
Food Chem Toxicol; 2005 Sep; 43(9):1441-7. PubMed ID: 15951091
[TBL] [Abstract][Full Text] [Related]
4. Human experimental exposure study on the uptake and urinary elimination of N-methyl-2-pyrrolidone (NMP) during simulated workplace conditions.
Bader M; Wrbitzky R; Blaszkewicz M; van Thriel C
Arch Toxicol; 2007 May; 81(5):335-46. PubMed ID: 17103143
[TBL] [Abstract][Full Text] [Related]
5. Determination of 5-hydroxy-N-methyl-2-pyrrolidone and 2-hydroxy-N-methylsuccinimide in human plasma and urine using liquid chromatography-electrospray tandem mass spectrometry.
Carnerup MA; Akesson B; Jönsson BA
J Chromatogr B Biomed Sci Appl; 2001 Sep; 761(1):107-13. PubMed ID: 11585124
[TBL] [Abstract][Full Text] [Related]
6. Human volunteer study on the inhalational and dermal absorption of N-methyl-2-pyrrolidone (NMP) from the vapour phase.
Bader M; Wrbitzky R; Blaszkewicz M; Schäper M; van Thriel C
Arch Toxicol; 2008 Jan; 82(1):13-20. PubMed ID: 17721780
[TBL] [Abstract][Full Text] [Related]
7. Determination of N-methylsuccinimide and 2-hydroxy-N-methylsuccinimide in human urine and plasma.
Jönsson BA; Akesson B
J Chromatogr B Biomed Sci Appl; 1997 Dec; 704(1-2):151-8. PubMed ID: 9518144
[TBL] [Abstract][Full Text] [Related]
8. Comparative developmental toxicities of the three major metabolites of N-methyl-2-pyrrolidone after oral administration in rats.
Saillenfait AM; Sabaté JP; Gallissot F
J Appl Toxicol; 2007; 27(6):571-81. PubMed ID: 17370238
[TBL] [Abstract][Full Text] [Related]
9. Biomonitoring of exposure to N-methyl-2-pyrrolidone in workers of the automobile industry.
Meier S; Schindler BK; Koslitz S; Koch HM; Weiss T; Käfferlein HU; Brüning T
Ann Occup Hyg; 2013 Jul; 57(6):766-73. PubMed ID: 23337464
[TBL] [Abstract][Full Text] [Related]
10. Human volunteer study on the influence of exposure duration and dilution of dermally applied N-methyl-2-pyrrolidone (NMP) on the urinary elimination of NMP metabolites.
Keener SA; Wrbitzky R; Bader M
Int Arch Occup Environ Health; 2007 Feb; 80(4):327-34. PubMed ID: 16897094
[TBL] [Abstract][Full Text] [Related]
11. Contribution of CYP2E1 to N-methyl-2-pyrrolidone metabolism.
Ligocka D; Lison D; Haufroid V
Arch Toxicol; 2003 May; 77(5):261-6. PubMed ID: 12734639
[TBL] [Abstract][Full Text] [Related]
12. Biological monitoring of N-methyl-2-pyrrolidone using 5-hydroxy-N-methyl-2-pyrrolidone in plasma and urine as the biomarker.
Akesson B; Jönsson BA
Scand J Work Environ Health; 2000 Jun; 26(3):213-8. PubMed ID: 10901113
[TBL] [Abstract][Full Text] [Related]
13. Direct determination of N-methyl-2-pyrrolidone metabolites in urine by HPLC-electrospray ionization-MS/MS using deuterium-labeled compounds as internal standard.
Suzuki Y; Endo Y; Ogawa M; Yamamoto S; Takeuchi A; Nakagawa T; Onda N
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Nov; 877(29):3743-7. PubMed ID: 19744900
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of exposure biomarkers from percutaneous absorption of N-methyl-2-pyrrolidone.
Akesson B; Carnerup MA; Jönsson BA
Scand J Work Environ Health; 2004 Aug; 30(4):306-12. PubMed ID: 15458014
[TBL] [Abstract][Full Text] [Related]
15. Dermal exposure to aqueous solutions of N-methyl pyrrolidone.
Akrill P; Cocker J; Dixon S
Toxicol Lett; 2002 Aug; 134(1-3):265-9. PubMed ID: 12191887
[TBL] [Abstract][Full Text] [Related]
16. Metabolites of the alkyl pyrrolidone solvents NMP and NEP in 24-h urine samples of the German Environmental Specimen Bank from 1991 to 2014.
Ulrich N; Bury D; Koch HM; Rüther M; Weber T; Käfferlein HU; Weiss T; Brüning T; Kolossa-Gehring M
Int Arch Occup Environ Health; 2018 Nov; 91(8):1073-1082. PubMed ID: 30167791
[TBL] [Abstract][Full Text] [Related]
17. SPE-GC/FTD determination of N-methyl-2-pyrrolidone and its metabolites in urine.
Kubota R; Endo Y; Takeuchi A; Inoue Y; Ogata H; Ogawa M; Nakagawa T; Onda N; Endo G
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jul; 854(1-2):204-10. PubMed ID: 17485256
[TBL] [Abstract][Full Text] [Related]
18. Embryotoxic potential of N-methyl-pyrrolidone (NMP) and three of its metabolites using the rat whole embryo culture system.
Flick B; Talsness CE; Jäckh R; Buesen R; Klug S
Toxicol Appl Pharmacol; 2009 Jun; 237(2):154-67. PubMed ID: 19281833
[TBL] [Abstract][Full Text] [Related]
19. Ambient monitoring and biomonitoring of workers exposed to N-methyl-2-pyrrolidone in an industrial facility.
Bader M; Rosenberger W; Rebe T; Keener SA; Brock TH; Hemmerling HJ; Wrbitzky R
Int Arch Occup Environ Health; 2006 May; 79(5):357-64. PubMed ID: 16362322
[TBL] [Abstract][Full Text] [Related]
20. Biological monitoring and health effects of low-level exposure to N-methyl-2-pyrrolidone: a cross-sectional study.
Haufroid V; Jaeger VK; Jeggli S; Eisenegger R; Bernard A; Friedli D; Lison D; Hotz P
Int Arch Occup Environ Health; 2014 Aug; 87(6):663-74. PubMed ID: 24078144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
